glp 1 gip mechanism The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Tirzepatide's Unique Mechanism of Action

No serious acromegaly, hypoglycemia, or excessive IGF1 elevations reported at recommended dosages (builtin negative feedback prevents overshooting)

Your body will fight you, tooth and nail to maintain what it has decided is your set weight, and for a lot of people, that set weight is unhealthy, and its insidious, Pinn says

Dehydration potential For patients using GLP-1s to manage diabetes or lose weight, there is reason for concern that use of GLP-1s may diminish the hydration patients need to maintain a healthy ocular surface

Environmental factors: Exposure to heat, cold, wind, or sun can trigger rosacea flare-ups